Seven numbers in the abstract
Where each one falls
Only readable comparisons vote
Where it lands on the map
What it changes
Among 2 other studies
the abstract, start to end
… lower risk of all-cause mortality (RR: 0.98; 95%CI: 0.69-1.38; P = 0.90), cardiovascular mortality (RR: 1.13; 95% CI: 0.60, 2.15; P = 0.70), macrovascular events (RR: 0.87; 95%CI: 0.70-1.07; P = 0.19), heart failure (RR: 1.02; 95% CI:0.61-1.71; P = 0.95), and microvascular events (RR: 0.78; 95% CI:0.54-1.13; P = 0.19).
… higher risk of all-cause mortality (RR: 1.49; 95% CI: 1.02, 2.16) and cardiovascular mortality (RR: 2.21; 95% CI: 1.22, 4.00) compared …
← favours treatmentfavours comparator →
could be chanceAll-cause mortality
RR 0.980.69–1.38
Cardiovascular events
RR 1.130.60–2.15
Cardiovascular events
RR 0.870.70–1.07
Cardiovascular events
RR 1.020.61–1.71
Cardiovascular events
RR 0.780.54–1.13
All-cause mortality
RR 1.491.02–2.16
Cardiovascular events
RR 2.211.22–4.00
MetforminCardiovascular eventsAll-cause mortality
Metformin × cardiovascular eventshelps?mixed
unlikelylikely
0.50not counted
Metformin × all-cause mortalityhelps?one trial
unlikelylikely
0.50not counted
← favours treatmentfavours comparator →
1 / 6